Active, Not Recruiting
Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption
NCT04340596
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
- Locations
-
- Alabama CRS (Site ID# 31788) Birmingham, Alabama, United States
- UCLA CARE Center CRS Los Angeles, California, United States
- UCSD Antiviral Research Center CRS (Site ID: 701) San Diego, California, United States
- University of California, San Fransisco HIV/AIDS CRS San Francisco, California, United States